Here’s what’s on the CBC Health Unit’s watch list for 2026: New approaches to connecting people with family doctors, anticipated changes to cancer screening, misinformation and vaccine wariness, future uses for GLP-1 agonists (like Ozempic and Wegovy) and the morphing toxic drug crisis.